Co-Tareg 320/25 Mg 14 Tablets

Co-Tareg 320/25 Mg 14 Tablets

Description:

Co-Tareg 320/25 mg 14 tablets is a prescription antihypertensive medicine used to treat high blood pressure (hypertension) in adults. It combines two active ingredients, valsartan (an angiotensin II receptor blocker) and hydrochlorothiazide (a thiazide diuretic), to provide effective blood pressure control when a single agent is insufficient. By relaxing blood vessels and increasing the excretion of excess salt and water, Co-Tareg helps lower blood pressure, reduce cardiovascular risk, and support long-term heart and kidney protection as part of a comprehensive hypertension management plan.

Indications:

• Treatment of essential hypertension (high blood pressure) in adults.
• Indicated in patients whose blood pressure is not adequately controlled by valsartan or hydrochlorothiazide alone.
• Helps reduce the risk of complications associated with uncontrolled hypertension such as stroke, heart attack, and cardiovascular events (as part of overall risk management under medical supervision).
• May be used as a replacement therapy in patients already stabilized on the individual components taken separately at the same doses.

Active Ingredients / Key Components:

• Valsartan – 320 mg per film-coated tablet (angiotensin II receptor blocker, ARB).
• Hydrochlorothiazide – 25 mg per film-coated tablet (thiazide diuretic).
• Other excipients (tablet core and film coating such as fillers, binders, colorants, and coating agents) – exact composition and concentrations , please check the product leaflet or the manufacturer’s official website; please refer to the official package leaflet for the full excipient list.

Dosage & Administration / How to Use:

• Co-Tareg 320/25 mg is for oral use only and should be taken exactly as prescribed by your physician.
• Typical adult dose: one tablet once daily. The exact dose and duration are determined by the treating doctor based on blood pressure response and individual patient factors.
• Can be taken with or without food. Take with a glass of water at the same time each day to maintain consistent blood levels.
• Do not crush or chew the tablets; swallow whole unless your doctor advises otherwise.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed tablet.
• Do not stop taking Co-Tareg suddenly without consulting your doctor, as this may cause your blood pressure to rise again.
• Regular monitoring of blood pressure, kidney function, and electrolytes (especially potassium, sodium, and magnesium) is recommended during treatment.

Clinical Benefits:

• Provides dual mechanism blood pressure control by blocking the effects of angiotensin II (valsartan) and promoting salt and water excretion (hydrochlorothiazide).
• Helps reduce elevated blood pressure, thereby lowering the risk of stroke, heart attack, and other cardiovascular complications when used as part of a comprehensive treatment plan.
• Offers convenient once-daily dosing, improving treatment adherence in patients requiring combination therapy.
• Hydrochlorothiazide supports additional blood pressure reduction through diuresis and decreased peripheral vascular resistance.
• Valsartan selectively blocks angiotensin II receptors, leading to vasodilation and reduced aldosterone secretion without affecting bradykinin breakdown (lower risk of cough compared with ACE inhibitors).

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to valsartan, hydrochlorothiazide, other sulfonamide-derived drugs, or any component of the product.
• Contraindicated during pregnancy, especially in the second and third trimesters, due to risk of fetal injury and death. If pregnancy is detected, stop Co-Tareg immediately and contact your doctor.
• Contraindicated in severe kidney impairment, anuria (inability to produce urine), or severe liver impairment, biliary cirrhosis, or cholestasis, unless specifically assessed and approved by a specialist.
• Use with caution in patients with renal artery stenosis, heart failure, electrolyte imbalances (such as low sodium, low potassium, or low magnesium), gout, diabetes, or a history of severe allergic reactions.
• May cause electrolyte disturbances (including low potassium, low sodium, low magnesium) and changes in kidney function; regular blood tests may be required.
• Hydrochlorothiazide may increase uric acid and blood glucose levels; caution in patients with gout or diabetes.
• May cause dizziness or fatigue, especially at the start of treatment or when the dose is increased; avoid driving or operating machinery until you know how the medicine affects you.
• Avoid concomitant use with aliskiren in patients with diabetes or impaired renal function, and use caution with other medicines that affect the renin-angiotensin-aldosterone system (ACE inhibitors, ARBs).
• Consult your doctor before use if pregnant, nursing, taking other medications (such as lithium, NSAIDs, potassium supplements, or potassium-sparing diuretics), or if you have medical conditions including kidney disease, liver disease, heart failure, gout, or diabetes.
• Not intended to diagnose, treat, cure, or prevent any disease without medical supervision. This is a prescription-only medicine and must be used under the guidance of a healthcare professional.
• Keep out of reach of children.

Side Effects:

• Common side effects may include dizziness, headache, fatigue, low blood pressure (hypotension), and mild gastrointestinal discomfort such as nausea or abdominal pain.
• Hydrochlorothiazide-related effects may include increased urination, electrolyte disturbances (low potassium, low sodium, low magnesium), increased uric acid (risk of gout), and changes in blood glucose or lipid levels.
• Less common but potentially serious side effects include severe hypotension, kidney function impairment, severe electrolyte imbalance, allergic reactions (rash, itching, swelling, difficulty breathing), and eye symptoms such as sudden decrease in vision or eye pain (possible acute angle-closure glaucoma – seek urgent medical help).
• Stop the medicine and seek immediate medical attention if you experience signs of severe allergic reaction, severe dizziness or fainting, difficulty breathing, swelling of the face, lips, tongue, or throat, or any other unusual or severe symptoms.
• This is not a complete list of side effects. For full details, consult the package leaflet and your healthcare provider.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed in the original blister pack to protect from moisture. Keep out of reach of children.

Specifications:

• Product type: Prescription antihypertensive medicine (combination of ARB and thiazide diuretic).
• Strength: 320 mg valsartan / 25 mg hydrochlorothiazide per film-coated tablet.
• Form: Film-coated tablets for oral use.
• Pack size: 14 tablets per pack.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.